Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luciano Adorini

Showing results (11-20 of 129) with videos related to

Pageof 13
Sort By:
Handbook of Experimental Pharmacology|November 26, 2008
Induction of tolerogenic dendritic cells by vitamin D receptor agonistsLuciano Adorini, Giuseppe Penna
Nature Clinical Practice. Rheumatology|July 3, 2008
Control of autoimmune diseases by the vitamin D endocrine systemLuciano Adorini, Giuseppe Penna
Expert Opinion on Therapeutic Targets|September 20, 2006
The vitamin D receptor as a therapeutic targetMoray J Campbell, Luciano Adorini
Seminars in Immunology|March 24, 2004
Pharmacological induction of tolerogenic dendritic cells and regulatory T cellsLuciano Adorini, Nadia Giarratana, Giuseppe Penna
Methods in Molecular Biology (Clifton, N.J.)|September 19, 2007
Animal models of spontaneous autoimmune disease: type 1 diabetes in the nonobese diabetic mouseNadia Giarratana, Giuseppe Penna, Luciano Adorini
Drug Discovery Today|June 2, 2012
Farnesoid X receptor targeting to treat nonalcoholic steatohepatitisLuciano Adorini, Mark Pruzanski, David Shapiro
Current Topics in Medicinal Chemistry|July 20, 2006
Vitamin D receptor agonists, cancer and the immune system: an intricate relationshipLuciano Adorini, Kenn C Daniel, Giuseppe Penna
Trends in Molecular Medicine|February 14, 2002
Understanding autoimmune diabetes: insights from mouse modelsLuciano Adorini, Silvia Gregori, Leonard C Harrison
Transplantation|July 9, 2005
Inhibition of acute and chronic allograft rejection in mouse models by BXL-628, a nonhypercalcemic vitamin D receptor agonistSusana Amuchastegui, Kenn C Daniel, Luciano Adorini
Immunology Letters|August 2, 2005
Prevention of chronic allograft rejection by Vitamin D receptor agonistsLuciano Adorini, Susana Amuchastegui, Kenn C Daniel
Pageof 13

Showing results (11-20 of 129) with videos related to

Sort By:
Pageof 13
Handbook of Experimental Pharmacology|November 26, 2008
Induction of tolerogenic dendritic cells by vitamin D receptor agonistsLuciano Adorini, Giuseppe Penna
Nature Clinical Practice. Rheumatology|July 3, 2008
Control of autoimmune diseases by the vitamin D endocrine systemLuciano Adorini, Giuseppe Penna
Expert Opinion on Therapeutic Targets|September 20, 2006
The vitamin D receptor as a therapeutic targetMoray J Campbell, Luciano Adorini
Seminars in Immunology|March 24, 2004
Pharmacological induction of tolerogenic dendritic cells and regulatory T cellsLuciano Adorini, Nadia Giarratana, Giuseppe Penna
Methods in Molecular Biology (Clifton, N.J.)|September 19, 2007
Animal models of spontaneous autoimmune disease: type 1 diabetes in the nonobese diabetic mouseNadia Giarratana, Giuseppe Penna, Luciano Adorini
Drug Discovery Today|June 2, 2012
Farnesoid X receptor targeting to treat nonalcoholic steatohepatitisLuciano Adorini, Mark Pruzanski, David Shapiro
Current Topics in Medicinal Chemistry|July 20, 2006
Vitamin D receptor agonists, cancer and the immune system: an intricate relationshipLuciano Adorini, Kenn C Daniel, Giuseppe Penna
Trends in Molecular Medicine|February 14, 2002
Understanding autoimmune diabetes: insights from mouse modelsLuciano Adorini, Silvia Gregori, Leonard C Harrison
Transplantation|July 9, 2005
Inhibition of acute and chronic allograft rejection in mouse models by BXL-628, a nonhypercalcemic vitamin D receptor agonistSusana Amuchastegui, Kenn C Daniel, Luciano Adorini
Immunology Letters|August 2, 2005
Prevention of chronic allograft rejection by Vitamin D receptor agonistsLuciano Adorini, Susana Amuchastegui, Kenn C Daniel
Pageof 13